Bayesian – Page 23 – Communicable Diseases Research

The Economic Impact of the SARS-COV-2 (COVID-19) Pandemic in Spain

Article

Published on 2021-04-282022-10-29
Journal: International Journal of Environmental Research an [Category] COVID-19, MERS, SARS,

High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients

회복기 혈장에서 높은 수준의 일반적인 감기 코로나바이러스 항체는 COVID-19 환자의 생존율 향상과 관련이 있습니다

Clinical Trial

Published on 2021-04-282022-08-13
Journal: Frontiers in Immunology [Category] MERS, SARS, 임상, 진단,

[키워드] Administered age Anderson Cancer Center anti-HCoV-HKU1 spike IgG anti-HCoV-OC43 anti-HCoV-OC43 spike IgG anti-SARS-CoV-2 antibodies antibody antibody levels Antigen antigens association Bayesian Bayesian exponential survival time regression model Cancer patients CCP CCP administration Cold common common cold convalescent plasma coronavirus coronavirus antibodies coronavirus strains COVID-19 COVID-19 convalescent plasma COVID-19 infection COVID-19-related complications died domain early stage effective Factor female HCoV-HKU1 HCoV-OC43 HKU1 Hospitalized identify IgG antibodies Improved Level MD Anderson Cancer Center median age moderate moderate to severe monoclonal antibody non-SARS-CoV-2-specific antibodies OC43 Other other coronaviruses outcomes Patient PBE PBEs posterior probability prognostic variable prognostic variables quantified Regression model Result Safe SARS-CoV-2 SARS-CoV-2-specific antibody Severe COVID-19 Infection Sex specific antibodies specific antibody spike IgG survival survival time the disease therapeutic target
[DOI] 10.3389/fimmu.2021.675679 PMC 바로가기 [Article Type] Clinical Trial

Estimating the effectiveness of routine asymptomatic PCR testing at different frequencies for the detection of SARS-CoV-2 infections

SARS-CoV-2 감염 감지를 위한 다양한 빈도의 일상적인 무증상 PCR 검사의 효과 추정

Research Article

Published on 2021-04-272022-09-01
Journal: BMC Medicine [Category] MERS, 진단,

[키워드] Asymptomatic Asymptomatic case Asymptomatic cases asymptomatic infection Bayesian Care Course COVID-19 dataset detect Effectiveness estimates Frequency healthcare worker Healthcare workers help hospital infected individual infected individuals Infection medical staff Nasopharyngeal swab notification outbreak PCR PCR test PCR testing peaked performed populations positive PCR test Presymptomatic infections Prevent Probability proportion provided Result returned routine RT-PCR SARS-CoV-2 SARS-COV-2 infection sensitivity statistical model supplementary material symptom onset symptomatic case symptomatic cases symptomatic infection Symptoms test results Test sensitivity twice weekly Vulnerable populations
[DOI] 10.1186/s12916-021-01982-x PMC 바로가기 [Article Type] Research Article

Interleukin-6 Receptor Antagonists in Critically Ill Patients with Covid-19

코비드-19에 걸린 중환자의 인터루킨-6 수용체 길항제

Randomized Controlled Trial

Published on 2021-04-222022-09-12
Journal: The New England Journal of Medicine [Category] Fulltext, MERS, 임상, 진단,

[키워드] 24 hour Adaptive platform trial adjusted Adult patient Analysis antagonist antagonists assigned Bayesian control group coronavirus disease criteria Critically ill patient cumulative odds ratio Efficacy evaluated greater groups hazard ratio ICU ICUs Ill In-hospital death intensive care interleukin-6 receptor International interquartile range median multifactorial Odds ratio organ organ support outcomes Patient posterior probability Primary outcome Randomly receive receiving REMAP-CAP sarilumab secondary analysis standard care statistical model supported survival Tocilizumab Treatment Trial yielding
[DOI] 10.1056/NEJMoa2100433 PMC 바로가기 [Article Type] Randomized Controlled Trial

Modelling the impact of the tier system on SARS-CoV-2 transmission in the UK between the first and second national lockdowns

첫 번째와 두 번째 국가 잠금 사이에 영국에서 SARS-CoV-2 전송에 대한 계층 시스템의 영향 모델링

Epidemiology

Published on 2021-04-222022-09-10
Journal: BMJ Open [Category] Fulltext, MERS, SARS, 변종,

Inferring UK COVID‐19 fatal infection trajectories from daily mortality data: Were infections already in decline before the UK lockdowns?

Biometric Practice

Published on 2021-04-072022-10-28
Journal: Biometrics [Category] COVID-19, MERS, SARS,

SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study

프랑스 전국 봉쇄 기간 동안 어린이집 어린이와 직원 간 SARS-CoV-2 전파: 횡단면, 다기관, 혈청 유병률 연구

Clinical Trial

Published on 2021-04-012022-09-12
Journal: The Lancet. Child & adolescent health [Category] MERS, SARS, 임상, 진단,

[키워드] 95% CI Abstract age antibody assistance Bayesian Characteristics children Comparator group contribute COVID-19 CrI cross-sectional Denis enrolled Epidemiological study exploratory Exploratory analysis France French Hypothesis IgG IgM test immunoassay individual laboratory-confirmed lockdown material multicentre nine Paris participant patients with COVID-19 positive presence of antibody Prevalence Primary outcome proportion Registered remained risk Saint SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 seroprevalence SARS-CoV-2 transmission Seine Sensitivity and specificity serological test seronegative seropositive suggested translation Transmission transmission of SARS-CoV-2 was measured Whole blood
[DOI] 10.1016/S2352-4642(21)00024-9 PMC 바로가기 [Article Type] Clinical Trial

Pandemic velocity: Forecasting COVID-19 in the US with a machine learning & Bayesian time series compartmental model

Research Article

Published on 2021-03-292022-10-28
Journal: PLoS Computational Biology [Category] COVID-19, SARS,

Spatial and temporal trends in social vulnerability and COVID-19 incidence and death rates in the United States

Research Article

Published on 2021-03-242022-10-28
Journal: PLoS ONE [Category] COVID-19, MERS, SARS,

Azithromycin for community treatment of suspected COVID-19 in people at increased risk of an adverse clinical course in the UK (PRINCIPLE): a randomised, controlled, open-label, adaptive platform trial

영국에서 불리한 임상 경과의 위험이 높은 사람들에서 COVID-19가 의심되는 지역사회 치료를 위한 아지스로마이신(원칙): 무작위, 통제, 공개, 적응 플랫폼 시험

Randomized Controlled Trial

Published on 2021-03-202022-08-13
Journal: Lancet (London, England) [Category] Fulltext, SARS, 임상, 치료법,

[키워드] adaptive Adaptive platform trial Admission analysed anti-inflammatory properties antibiotic Antibiotics antimicrobial resistance Antiviral assigned Azithromycin azothromycin Bayesian Bayesian logistic regression model Bayesian piecewise exponential Bayesian primary analysis BCI benefit both groups Clinical course clinically Community Comorbidity complications COVID-19 credibility interval death Department Effectiveness Eligible participants Endpoint enrolled Evidence evidence of finding Follow-up funding groups hazard ratio hospital Hospital admission hospitalisation hospitalised implication in both groups increased risk Innovation Intervention ISRCTN leads less logistic regression model median time multi-arm Older Open-label outcome pandemic participant platform primary analysis primary care principle Probability provided randomisation randomised Randomised trial Randomly recruited reducing Registered reported risk Safety safety analysis study group Time to recovery treat Treatment Trial use of antibiotics usual care usual care alone usual care group
[DOI] 10.1016/S0140-6736(21)00461-X PMC 바로가기 [Article Type] Randomized Controlled Trial